What Happened?
Shares of medical device company Merit Medical Systems (NASDAQ: MMSI) jumped 4.6% in the afternoon session after Needham reiterated its "Buy" rating and a $108 price target on the stock.
The analyst's reaffirmed confidence on July 8, 2025, signals a belief that the medical device company continues to be a solid investment.
This comes on the heels of the company's announcement on July 7 that it had appointed Martha Aronson as its new President and CEO, with founder Fred Lampropoulos transitioning to Chairman of the Board. Adding to the positive sentiment, Merit Medical also released strong preliminary revenue results for the second quarter of 2025, expecting between $380 million and $384 million. The combination of leadership stability, strong preliminary sales, and bullish analyst sentiment appears to be driving investor optimism.
Is now the time to buy Merit Medical Systems? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Merit Medical Systems’s shares are not very volatile and have only had 3 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
Merit Medical Systems is down 0.3% since the beginning of the year, and at $95.78 per share, it is trading 13.2% below its 52-week high of $110.29 from January 2025. Investors who bought $1,000 worth of Merit Medical Systems’s shares 5 years ago would now be looking at an investment worth $2,188.
Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free and will only take you a second.
